Insiders · SAGE

SAGE insider transactions

Sage Therapeutics Inc. (SAGE) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for SAGE

• 312d
  Officer Quirk Michael C. returned 32,961 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 312d
  SEC Form 4 filed by Director Federer Jessica

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 312d
  Chief Operating Officer Benecchi Christopher returned 64,428 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 312d
  SEC Form 4 filed by Director Cola Michael F

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 312d
  Director Barrett Elizabeth A. closing all direct ownership in the company (SEC Form 4)

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 312d
  Director Golumbeski George closing all direct ownership in the company (SEC Form 4)

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 312d
  SEC Form 4 filed by Director Germano Geno J

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 312d
  Director Frates James M closing all direct ownership in the company (SEC Form 4)

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 312d
  Officer Shiferman Gregory L. returned 23,735 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 312d
  President and CEO Greene Barry E returned 53,229 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 346d
  Officer Quirk Michael C. covered exercise/tax liability with 113 shares, decreasing direct ownership by 0.37% to 30,461 units (SEC Form 4)

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 346d
  Officer Shiferman Gregory L. covered exercise/tax liability with 79 shares, decreasing direct ownership by 0.25% to 30,950 units (SEC Form 4)

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 359d
  SEC Form 4 filed by Director Germano Geno J

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 359d
  SEC Form 4 filed by Director Golumbeski George

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 359d
  SEC Form 4 filed by Director Frates James M

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 359d
  SEC Form 4 filed by Director Federer Jessica

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 359d
  SEC Form 4 filed by Director Cola Michael F

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 359d
  SEC Form 4 filed by Director Barrett Elizabeth A.

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 431d
  Officer Quirk Michael C. was granted 2,000 shares, increasing direct ownership by 7% to 29,108 units (SEC Form 4)

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 431d
  New insider Quirk Michael C. claimed ownership of 27,108 shares (SEC Form 3)

  3 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 438d
  Officer Shiferman Gregory L. covered exercise/tax liability with 79 shares, decreasing direct ownership by 0.26% to 30,680 units (SEC Form 4)

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 467d
  Officer Shiferman Gregory L. covered exercise/tax liability with 2,502 shares, decreasing direct ownership by 8% to 30,759 units (SEC Form 4)

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 478d
  Chief Operating Officer Benecchi Christopher covered exercise/tax liability with 822 shares, decreasing direct ownership by 2% to 43,915 units (SEC Form 4)

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 478d
  Chief Medical Officer Gault Laura covered exercise/tax liability with 685 shares, decreasing direct ownership by 2% to 34,649 units (SEC Form 4)

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 478d
  Officer Shiferman Gregory L. covered exercise/tax liability with 627 shares, decreasing direct ownership by 2% to 33,261 units (SEC Form 4)

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 502d
  Officer Shiferman Gregory L. was granted 14,000 shares, increasing direct ownership by 70% to 33,888 units (SEC Form 4)

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 502d
  SEC Form 4 filed by President and CEO Greene Barry E

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 502d
  Chief Medical Officer Gault Laura was granted 24,000 shares, increasing direct ownership by 212% to 35,334 units (SEC Form 4)

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 502d
  Chief Operating Officer Benecchi Christopher was granted 20,000 shares, increasing direct ownership by 81% to 44,737 units (SEC Form 4)

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 517d
  SEC Form 4 filed by Director Golumbeski George

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 517d
  SEC Form 4 filed by Director Frates James M

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 527d
  Officer Shiferman Gregory L. covered exercise/tax liability with 79 shares, decreasing direct ownership by 0.40% to 19,888 units (SEC Form 4)

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 570d
  Chief Operating Officer Benecchi Christopher was granted 6,250 shares, increasing direct ownership by 34% to 24,737 units (SEC Form 4)

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 583d
  Officer Shiferman Gregory L. was granted 5,000 shares, increasing direct ownership by 33% to 19,967 units (SEC Form 4)

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 583d
  New insider Shiferman Gregory L. claimed ownership of 14,967 shares (SEC Form 3)

  3 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 669d
  Chief Medical Officer Gault Laura was granted 13,500 shares and covered exercise/tax liability with 3,288 shares, increasing direct ownership by 1,945% to 10,737 units (SEC Form 4)

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 669d
  President and CEO Greene Barry E was granted 50,400 shares and covered exercise/tax liability with 12,273 shares, increasing direct ownership by 81% to 85,067 units (SEC Form 4)

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 669d
  CFO & Treasurer Iguchi Kimi was granted 13,500 shares and covered exercise/tax liability with 3,636 shares, increasing direct ownership by 14% to 81,405 units (SEC Form 4)

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 669d
  SVP, GC & Secretary Cook Anne Marie was granted 13,500 shares and covered exercise/tax liability with 4,503 shares, increasing direct ownership by 60% to 24,040 units (SEC Form 4)

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 669d
  Chief Business Officer Benecchi Christopher was granted 16,200 shares and covered exercise/tax liability with 4,755 shares, increasing direct ownership by 163% to 18,487 units (SEC Form 4)

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 726d
  SEC Form 4 filed by Director Jonas Jeffrey M

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 726d
  SEC Form 4 filed by Director Germano Geno J

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 726d
  SEC Form 4 filed by Director Golumbeski George

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 726d
  SEC Form 4 filed by Director Frates James M

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 726d
  SEC Form 4 filed by Director Cola Michael F

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 726d
  SEC Form 4 filed by Director Barrett Elizabeth

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 726d
  SEC Form 4 filed by Director Federer Jessica

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 843d
  Cook Anne Marie was granted 11,250 shares, increasing direct ownership by 81% to 25,181 units (SEC Form 4)

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 843d
  SEC Form 4 filed by Greene Barry E

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 843d
  Gault Laura was granted 11,250 shares, increasing direct ownership by 4,956% to 11,477 units (SEC Form 4)

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 843d
  Benecchi Christopher was granted 13,500 shares, increasing direct ownership by 228% to 19,430 units (SEC Form 4)

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 843d
  Iguchi Kimi was granted 11,250 shares, increasing direct ownership by 16% to 81,679 units (SEC Form 4)

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 885d
  SEC Form 4 filed by Paul Steven M

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 885d
  SEC Form 4 filed by Federer Jessica

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 885d
  SEC Form 4 filed by Frates James M

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 885d
  SEC Form 4 filed by Golumbeski George

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 885d
  Iguchi Kimi exercised 1,642 shares at a strike of $1.36, increasing direct ownership by 2% to 70,429 units (SEC Form 4)

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 920d
  Jonas Jeffrey M was granted 10,000 shares and covered exercise/tax liability with 3,935 shares, increasing direct ownership by 5% to 128,046 units (SEC Form 4)

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 920d
  Cook Anne Marie was granted 4,000 shares and covered exercise/tax liability with 1,174 shares, increasing direct ownership by 26% to 13,716 units (SEC Form 4)

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)
• 920d
  Iguchi Kimi was granted 3,500 shares and covered exercise/tax liability with 943 shares, increasing direct ownership by 4% to 68,787 units (SEC Form 4)

  4 - Sage Therapeutics, Inc. (0001597553) (Issuer)